What is GTLB's health score?

Gitlab Inc. (GTLB) has a TradeApes health score of 44 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is GTLB's estimated fair value?

Based on our 5-year discounted cash flow model, Gitlab Inc.'s estimated fair value is $12.32 per share, representing a -60.4% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is GTLB undervalued or overvalued?

Our model currently rates GTLB as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for GTLB... Refresh in a moment for the full analysis.

Gitlab Inc. (GTLB)

Technology Overvalued low weak

$31.12

Updated: 2026-06-06

TradeApes Score

Financial Strength

35 Weak

Operating Trend

40 Weak

Relative Value

55 Mixed

Capital Allocation

30 Weak

Risk

70 Healthy

Est. Fair Value $12.32

DCF Upside -60.4%

Sector Rank #739 of 7892

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.